Literature DB >> 21238945

Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment.

Simon Reiss1, Ilka Rebhan, Perdita Backes, Ines Romero-Brey, Holger Erfle, Petr Matula, Lars Kaderali, Marion Poenisch, Hagen Blankenburg, Marie-Sophie Hiet, Thomas Longerich, Sarah Diehl, Fidel Ramirez, Tamas Balla, Karl Rohr, Artur Kaul, Sandra Bühler, Rainer Pepperkok, Thomas Lengauer, Mario Albrecht, Roland Eils, Peter Schirmacher, Volker Lohmann, Ralf Bartenschlager.   

Abstract

Hepatitis C virus (HCV) is a major causative agent of chronic liver disease in humans. To gain insight into host factor requirements for HCV replication, we performed a siRNA screen of the human kinome and identified 13 different kinases, including phosphatidylinositol-4 kinase III alpha (PI4KIIIα), as being required for HCV replication. Consistent with elevated levels of the PI4KIIIα product phosphatidylinositol-4-phosphate (PI4P) detected in HCV-infected cultured hepatocytes and liver tissue from chronic hepatitis C patients, the enzymatic activity of PI4KIIIα was critical for HCV replication. Viral nonstructural protein 5A (NS5A) was found to interact with PI4KIIIα and stimulate its kinase activity. The absence of PI4KIIIα activity induced a dramatic change in the ultrastructural morphology of the membranous HCV replication complex. Our analysis suggests that the direct activation of a lipid kinase by HCV NS5A contributes critically to the integrity of the membranous viral replication complex. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21238945      PMCID: PMC3433060          DOI: 10.1016/j.chom.2010.12.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  43 in total

Review 1.  Phosphatidylinositol 4-kinases: old enzymes with emerging functions.

Authors:  Andras Balla; Tamas Balla
Journal:  Trends Cell Biol       Date:  2006-06-21       Impact factor: 20.808

2.  Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining patterns.

Authors:  Gamal E Shiha; Khaled R Zalata; Ahmed F Abdalla; Mostfa K Mohamed
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

3.  Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes.

Authors:  Torsten Schaller; Nicole Appel; George Koutsoudakis; Stephanie Kallis; Volker Lohmann; Thomas Pietschmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

4.  Nucleolar localization of phosphatidylinositol 4-kinase PI4K230 in various mammalian cells.

Authors:  Annamária Kakuk; Elza Friedländer; György Vereb; Anita Kása; András Balla; Tamás Balla; Ludwig M G Heilmeyer; Pál Gergely; György Vereb
Journal:  Cytometry A       Date:  2006-12-01       Impact factor: 4.355

5.  Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening.

Authors:  Maud Trotard; Charlotte Lepère-Douard; Morgane Régeard; Claire Piquet-Pellorce; Dimitri Lavillette; François-Loic Cosset; Philippe Gripon; Jacques Le Seyec
Journal:  FASEB J       Date:  2009-07-16       Impact factor: 5.191

Review 6.  Cellular and molecular biology of HCV infection and hepatitis.

Authors:  Hengli Tang; Henry Grisé
Journal:  Clin Sci (Lond)       Date:  2009-06-15       Impact factor: 6.124

7.  RNA interference screen for human genes associated with West Nile virus infection.

Authors:  Manoj N Krishnan; Aylwin Ng; Bindu Sukumaran; Felicia D Gilfoy; Pradeep D Uchil; Hameeda Sultana; Abraham L Brass; Rachel Adametz; Melody Tsui; Feng Qian; Ruth R Montgomery; Sima Lev; Peter W Mason; Raymond A Koski; Stephen J Elledge; Ramnik J Xavier; Herve Agaisse; Erol Fikrig
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

8.  Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.

Authors:  Kristi L Berger; Jacob D Cooper; Nicholas S Heaton; Rosa Yoon; Todd E Oakland; Tristan X Jordan; Guaniri Mateu; Arash Grakoui; Glenn Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-17       Impact factor: 11.205

9.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles.

Authors:  Takahiro Masaki; Ryosuke Suzuki; Kyoko Murakami; Hideki Aizaki; Koji Ishii; Asako Murayama; Tomoko Date; Yoshiharu Matsuura; Tatsuo Miyamura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

View more
  263 in total

Review 1.  Lipids at the interface of virus-host interactions.

Authors:  Vineela Chukkapalli; Nicholas S Heaton; Glenn Randall
Journal:  Curr Opin Microbiol       Date:  2012-06-09       Impact factor: 7.934

Review 2.  Unique ties between hepatitis C virus replication and intracellular lipids.

Authors:  Eva Herker; Melanie Ott
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

Review 3.  Architecture and biogenesis of plus-strand RNA virus replication factories.

Authors:  David Paul; Ralf Bartenschlager
Journal:  World J Virol       Date:  2013-05-12

Review 4.  High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay.

Authors:  Sandeep Amberkar; Narsis A Kiani; Ralf Bartenschlager; Gualtiero Alvisi; Lars Kaderali
Journal:  World J Virol       Date:  2013-05-12

5.  USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.

Authors:  Shinji Kusakabe; Tatsuya Suzuki; Yukari Sugiyama; Saori Haga; Kanako Horike; Makoto Tokunaga; Junki Hirano; He Zhang; David Virya Chen; Hanako Ishiga; Yasumasa Komoda; Chikako Ono; Takasuke Fukuhara; Masahiro Yamamoto; Masahito Ikawa; Takashi Satoh; Shizuo Akira; Tomohisa Tanaka; Kohji Moriishi; Moto Fukai; Akinobu Taketomi; Sachiyo Yoshio; Tatsuya Kanto; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  Quantitative proteomic analysis of host-virus interactions reveals a role for Golgi brefeldin A resistance factor 1 (GBF1) in dengue infection.

Authors:  Lindsay N Carpp; Richard S Rogers; Robert L Moritz; John D Aitchison
Journal:  Mol Cell Proteomics       Date:  2014-05-22       Impact factor: 5.911

7.  Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B.

Authors:  Katharina Esser-Nobis; Inés Romero-Brey; Tom M Ganten; Jérôme Gouttenoire; Christian Harak; Rahel Klein; Peter Schemmer; Marco Binder; Paul Schnitzler; Darius Moradpour; Ralf Bartenschlager; Stephen J Polyak; Wolfgang Stremmel; François Penin; Christoph Eisenbach; Volker Lohmann
Journal:  Hepatology       Date:  2013-02-07       Impact factor: 17.425

8.  ADP ribosylation factor 1 plays an essential role in the replication of a plant RNA virus.

Authors:  Kiwamu Hyodo; Akira Mine; Takako Taniguchi; Masanori Kaido; Kazuyuki Mise; Hisaaki Taniguchi; Tetsuro Okuno
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  Novel dengue virus NS2B/NS3 protease inhibitors.

Authors:  Hongmei Wu; Stefanie Bock; Mariya Snitko; Thilo Berger; Thomas Weidner; Steven Holloway; Manuel Kanitz; Wibke E Diederich; Holger Steuber; Christof Walter; Daniela Hofmann; Benedikt Weißbrich; Ralf Spannaus; Eliana G Acosta; Ralf Bartenschlager; Bernd Engels; Tanja Schirmeister; Jochen Bodem
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

10.  Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection.

Authors:  Martina Friesland; Lidia Mingorance; Josan Chung; Francis V Chisari; Pablo Gastaminza
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.